A Review on Herbal Drugs Used For the Treatment of Psychiatric Disorder
Pharmaceutical Science-Pharmaceutics
DOI:
https://doi.org/10.22376/ijlpr.2023.13.SP1.P98-P106Keywords:
Depression, Bipolar Disorder, Herbal Medicine, Insomnia, Mechanism, PsychopharmacologyAbstract
Abstract: Only one-third of persons with psychiatric conditions such as bipolar disorder, psychosis, stress, anxiety, and depression get complete treatment, and the danger of relapse still exists. Additionally, they may result in several negative side effects, including impotence, constipation, dry mouth, and tiredness. Researchers are now looking for more specialized medications that are safer and cheaper. Researchers in this discipline has been interested in medicinal plants because they have historically been used to treat various illnesses, including mental problems, and because they have fewer side effects than synthetic & chemical medications. Western drugs have a wide range of adverse effects, and the number of individuals who experience them is rising. A comprehensive study on the use of herbal medicine for depression, anxiety, and sleeplessness is still missing. This review, which was carried out better to define the mechanisms of action of various herbal medicines, offers helpful data regarding the use of herbal medicine. Research on distress is abundant, but it's important to consider how well herbal remedies work for these conditions. Traditional medical systems are still used extensively on many fronts. Increased emphasis has been placed on using plant materials as a source of medicines for a wide range of human maladies as a result of factors like population growth, an inadequate supply of medications, prohibitive costs of treatments, side effects of some synthetic drugs, and the emergence of drug resistance to currently prescribed medications for infectious diseases. Objective- The overview covers all the pertinent topics in herbal treatment today, including safety concerns and potential future applications.
References
Abbasi Maleki S, Bekhradi R, Asgharpanah J, Abbasi Maleki F, Maleki A. Antidepressant effect of aqueous and hydroalcoholic extracts of Lavandula officinalis in forced swim test and tail suspension test in male mice. J Arak Univ Med Sci. 2013;16:65-75.
Ahmad H, Rauf K, Zada W, McCarthy M, Abbas G, Anwar F et al. Kaempferol facilitated extinction learning in contextual fear conditioned rats via inhibition of fatty-acid amide hydrolase. Molecules. 2020 Jan;25(20):4683. doi: 10.3390/molecules25204683, PMID 33066366.
Alrefaie Z. Grape seed proanthocyanidins Attentuate anxiety-like behavior in an experimental model of dietary-induced hypercholesterolemia in rats. Int J Vitam Nutr Res. 2016 Jul 14;1(1):1-0.
Kulkarni SK, Dhir A. Withania somnifera: an Indian ginseng. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jul 1;32(5):1093-105. doi: 10.1016/j.pnpbp.2007.09.011, PMID 17959291.
Hoenders R. Integrative psychiatry. Conceptual foundation, implementation and effectiveness. Inintegr Psychiatry Conceptual Found Implement Eff. 2013:(212-).
Hoenders HJ, Appelo MT, van den Brink EH, Hartogs BM, de Jong JT. The Dutch Complementary and Alternative Medicine (C.A.M.) protocol: to ensure the safe and effective use of complementary and alternative medicine within Dutch mental health care. J Altern Complement Med. 2011;17(12):1197-201. doi: 10.1089/acm.2010.0762, PMID 21506670.
7, Topliss JG, Clark AM, Ernst E, Hufford CD, Johnston GA, Rimoldi J.M. et al. Natural and synthetic substances related to human health [IUPAC technical report]. Pure and Applied Chemistry. Vol. 74(10); 2002 Jan 1. p. 1957-85.
Ernst E. Serious psychiatric and neurological adverse effects of herbal medicines–a systematic review. Acta Psychiatr Scand. 2003 Aug;108(2):83-91.
Hazra M, Noh S, Boon H, Taylor A, Moss K, Mamo DC. Complementary and alternative medicine in psychotic disorders. J Complement Integr Med. 2010 Sep 4;4(1):7(1). doi: 10.2202/1553-3840.1239.
Duggal S, Singh H, Singh J, Withanolides KS: Phytoconstituents with significant pharmacological activities. 5Singh A. Int J Green Pharm (IJGP). 2010;4(4).
Bhattacharya SK, Goel RK, Kaur R, Ghosal S. Anti-stress activity of sitoindosides VII and VIII, new acylsterylglucosides from Withania somnifera. Phytother Res. 1987 Mar;1(1):32-7. doi: 10.1002/ptr.2650010108.
Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med. 2012 Jul;34(3):255-62. doi: 10.4103/0253-7176.106022, PMID 23439798.
Cooley K, Szczurko O, Perri D, Mills EJ, Bernhardt B, Zhou Q et al. Naturopathic care for anxiety: a randomized controlled trial ISRCTN78958974. PLOS ONE. 2009 Aug 31;4(8):e6628. doi: 10.1371/journal.pone.0006628, PMID 19718255.
Sun B, Dilcher DL, Beerling DJ, Zhang C, Yan D, Kowalski E. Variation in Ginkgo biloba L. leaf characters across a climatic gradient in China. Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7141-6. doi: 10.1073/pnas.1232419100, PMID 12777617.
Nah SY, Kim DH, Rhim H. Ginsenosides: are any of them candidates for drugs acting on the central nervous system? C.N.S. Drug Rev. 2007 Dec;13(4):381-404. doi: 10.1111/j.1527-3458.2007.00023.x, PMID 18078425.
Dey A, Nath De J.N. Possible anti-Parkinson's disease therapeutics from nature: a review. Stud Nat Prod Chem. 2015 Jan 1;44:447-520. doi: 10.1016/B978-0-444-63460-3.00009-2.
Ong WY, Farooqui T, Koh HL, Farooqui AA, Ling EA. Protective effects of ginseng on neurological disorders. Front Aging Neurosci. 2015 Jul 16;7:129. doi: 10.3389/fnagi.2015.00129, PMID 26236231.
Pan Y, Wang J, Gao J, Li H, Chen H. Study on the Network Pharmacological Mechanism of Huanglian Wendan decoction in the treatment of depression; 2022.
Kim yh. ginsenosides from heat-processed korean ginseng roots, leaves and flower buds. inpharmaceutical biology 2012 may 1 (vol. 50, no. 5, pp. 569-570). telephone house, 69-77 paul street, london ec2a 4lq, england: informa healthcare.
Rajabian A, Rameshrad M, Hosseinzadeh H. Therapeutic potential of panax ginseng and its constituents, ginsenosides and gintonin, in neurological and neurodegenerative disorders: a patent review. Expert Opin Ther Pat. 2019 Jan 2;29(1):55-72. doi: 10.1080/13543776.2019.1556258, PMID 30513224.
Radad K, Gille G, Moldzio R, Saito H, Ishige K, Rausch WD. Ginsenosides Rb1 and Rg1 effects on survival and neurite growth of MPP+-affected mesencephalic dopaminergic cells. J Neural Transm (Vienna). 2004a;111(1):37-45. doi: 10.1007/s00702-003-0063-1, PMID 14714214.
Xu BB, Liu CQ, Gao X, Zhang WQ, Wang SW, Cao YL. Possible mechanisms of the protection of ginsenoside Re against MPTPinduced apoptosis in substantia nigra neurons of Parkinson’s disease mouse model. J Asian Nat Prod Res. 2005;7(3):215-24. doi: 10.1080/10286020410001690172, PMID 15621629.
Lin WM, Zhang YM, Moldzio R, Rausch WD. Ginsenoside Rd attenuates neuroinflammation of dopaminergic cells in culture. J Neural Transm Suppl. 2007;72:105-12.
Hwang YP, Jeong HG. Ginsenoside Rb1 protects against 6-hydroxydopamine-induced oxidative stress by increasing hemeoxygenase-1 expression through an estrogen receptor-related PI3K/Akt/Nrf2-dependent pathway in human dopaminergic cells. Toxicol Appl Pharmacol. 2010;242(1):18-28. doi: 10.1016/j.taap.2009.09.009.
Meng XB, Sun GB, Wang M, Sun J, Qin M, Sun XB. P90RSK and Nrf2 activation via MEK1/2-ERK1/2 pathways mediated by notoginsenoside R2 to prevent 6-hydroxydopamine-induced apoptotic death in SH-SY5Y cells. Evid Based Complement Alternat Med. 2013;2013:971712. doi: 10.1155/2013/971712, PMID 24159358.
Mei L, Mochizuki M, Hasegawa N. Pycnogenol ameliorates depression-like behavior in repeated corticosterone-induced depression mice model. BioMed Res Int. 2014 Jan 1;2014:942927. doi: 10.1155/2014/942927, PMID 24901001.
Alrefaie Z. Grape seed proanthocyanidins Attentuate anxiety-like behavior in an experimental model of dietary-induced hypercholesterolemia in rats. Int J Vitam Nutr Res. 2016 Jul 14;1(1):1-0.
Jiang C, Sakakibara E, Lin WJ, Wang J, Pasinetti GM, Salton SR. Grape-derived polyphenols produce antidepressant effects via V.G.F.- and BDNF-dependent mechanisms. Ann N Y Acad Sci. 2019 Nov;1455(1):196-205. doi: 10.1111/nyas.14098, PMID 31074515.
Sreemantula S, Nammi S, Kolanukonda R, Koppula S, Boini KM. Adaptogenic and nootropic activities of aqueous extract of Vitis vinifera (grape seed): an experimental study in rat model. BMC Complement Altern Med. 2005;5(1):1. doi: 10.1186/1472-6882-5-1, PMID 15656916.
Wang Y, Wang Y, Shen W, Wang Y, Cao Y, Nuerbulati N et al. Grape seed polyphenols ameliorated dextran sulfate sodium-induced colitis via suppression of inflammation and apoptosis. Pharmacology. 2020;105(1-2):9-18. doi: 10.1159/000501897, PMID 31743904.
Lian Q, Nie Y, Zhang X, Tan B, Cao H, Chen W, et al. Effects of grape seed proanthocyanidin on Alzheimer’s disease in vitro and in vivo. Exp Ther Med. 2016 Sep;12(3):1681-92. doi: 10.3892/etm.2016.3530, PMID 27588088.
Sun Q, Jia N, Li X, Yang J, Chen G. Grape seed proanthocyanidins ameliorate neuronal oxidative damage by inhibiting GSK-3β-dependent mitochondrial permeability transition pore opening in an experimental model of sporadic Alzheimer’s disease. Aging (Albany, NY). 2019 Jun 24;11(12):4107-24. doi: 10.18632/aging.102041, PMID 31232699.
Dhingra D, Sharma A. Evaluation of antidepressant-like activity of glycyrrhizin in mice. Indian J Pharmacol. 2005 Nov 1;37(6):390. doi: 10.4103/0253-7613.19077.
Gareri P, Condorelli D, Belluardo N, Russo E, Loiacono A, Barresi V et al. Anticonvulsant effects of carbenoxolone in genetically epilepsy prone rats (GEPRs). Neuropharmacology. 2004 Dec 1;47(8):1205-16. doi: 10.1016/j.neuropharm.2004.08.021, PMID 15567430.
Chakravarthi KK, Avadhani R, Narayan RS. Effect of Glycyrrhiza glabra root extract on learning and memory in Wistar albino rats. Drug Invent Today. 2012 Aug 5;4(7):387-90.
Butterweck V, Schmidt M. St. John’s wort: role of active compounds for its mechanism of action and efficacy. Wien Med Wochenschr. 2007 Jul;157(13-14):356-61. doi: 10.1007/s10354-007-0440-8, PMID 17704987.
Singer A, Schmidt M, Hauke W, Stade K. Duration of response after treatment of mild to moderate depression with Hypericum extract S.T.W. 3-VI, citalopram and placebo: A reanalysis of data from a controlled clinical trial. Phytomedicine. 2011;18(8-9):739-42. doi: 10.1016/j.phymed.2011.02.016, PMID 21514125.
Grundmann OL, Lv Y, Kelber O, Butterweck V. Mechanism of St. John’s wort extract (STW3-VI) during chronic restraint stress is mediated by the interrelationship of the immune, oxidative defense, and neuroendocrine system. Neuropharmacology. 2010 Mar 1;58(4-5):767-73. doi: 10.1016/j.neuropharm.2009.12.014, PMID 20036263.
Fajemiroye JO, da Silva DM, de Oliveira DR, Costa EA. Treatment of anxiety and depression: medicinal plants in retrospect. Fundam Clin Pharmacol. 2016 Jun;30(3):198-215. doi: 10.1111/fcp.12186, PMID 26851117.
Singh YN, Singh NN. Therapeutic potential of kava in the treatment of anxiety disorders. C.N.S. Drugs. 2002 Nov;16(11):731-43. doi: 10.2165/00023210-200216110-00002, PMID 12383029.
Wu D, Yu L, Nair MG, DeWitt DL, Ramsewak RS. Cyclooxygenase enzyme inhibitory compounds with antioxidant activities from Piper methysticum (kava-kava) roots. Phytomedicine. 2002;9(1):41-7. doi: 10.1078/0944-7113-00068, PMID 11924763.
Pittler MH, Ernst E. Efficacy of kava extract for treating anxiety: systematic review and meta-analysis. J Clin Psychopharmacol. 2000 Feb 1;20(1):84-9. doi: 10.1097/00004714-200002000-00014, PMID 10653213.
Hattesohl M, Feistel B, Sievers H, Lehnfeld R, Hegger M, Winterhoff H. Extracts of Valeriana officinalis L. sl show anxiolytic and antidepressant effects but neither sedative nor myorelaxant properties. Phytomedicine. 2008 Jan 25;15(1-2):2-15. doi: 10.1016/j.phymed.2007.11.027, PMID 18160026.
Volz HP, Murck H, Kasper S, Möller HJ. St John’s wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trial. Psychopharmacology. 2002 Nov;164(3):294-300. doi: 10.1007/s00213-002-1171-6, PMID 12424553.
Donath F, Quispe S, Diefenbach K, Maurer A, Fietze I, Roots I. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality. Pharmacopsychiatry. 2000 Mar;33(2):47-53. doi: 10.1055/s-2000-7972, PMID 10761819.
Benke D, Barberis A, Kopp S, Altmann KH, Schubiger M, Vogt KE et al. GABAA receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts. Neuropharmacology. 2009 Jan 1;56(1):174-81. doi: 10.1016/j.neuropharm.2008.06.013, PMID 18602406.
Andreatini R, Sartori VA, Seabra ML, Leite JR. Effect of valepotriates (valerian extract) in generalized anxiety disorder: a randomized placebo‐controlled pilot study. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives. Phytother Res. 2002 Nov;16(7):650-4. doi: 10.1002/ptr.1027, PMID 12410546.
Rojas P, Serrano-García N, Medina-Campos ON, Pedraza-Chaverri J, Ögren SO, Rojas C. Antidepressant-like effect of a Ginkgo biloba extract (EGb761) in the mouse forced swimming test: role of oxidative stress. Neurochem Int. 2011;59(5):628-36. doi: 10.1016/j.neuint.2011.05.007, PMID 21672588.
Mao JJ, Li QS, Soeller I, Rockwell K, Xie SX, Amsterdam JD. Long-term chamomile therapy of generalized anxiety disorder: A study protocol for a randomized, double-blind, placebo-controlled trial. J Clin Trials. 2014 Nov;4(5). doi: 10.4172/2167-0870.1000188, PMID 29057164.
Amsterdam JD, Li Y, Soeller I, Rockwell K, Mao JJ, Shults J. A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy of generalized anxiety disorder. J Clin Psychopharmacol. 2009 Aug;29(4):378-82. doi: 10.1097/J.C.P.0b013e3181ac935c, PMID 19593179.
Sarris J, Panossian A, Schweitzer I, Stough C, Scholey A. Herbal medicine for depression, anxiety and insomnia: a review of psychopharmacology and clinical evidence. Eur Neuropsychopharmacol. 2011;21(12):841-60. doi: 10.1016/j.euroneuro.2011.04.002, PMID 21601431.
Sarris J, Stough C, Bousman CA, Wahid ZT, Murray G, Teschke R et al. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study. J Clin Psychopharmacol. 2013;33(5):643-8. doi: 10.1097/J.C.P.0b013e318291be67, PMID 23635869.
Darbinyan V, Aslanyan G, Amroyan E, Gabrielyan E, Malmström C, Panossian A. Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression. Nord J Psychiatry. 2007;61(5):343-8. doi: 10.1080/08039480701643290, PMID 17990195.
Hiai S, Yokoyama H, Oura H. Features of ginseng saponin-induced corticosterone secretion. Endocrinol Jpn. 1979;26(6):737-40. doi: 10.1507/endocrj1954.26.737, PMID 396151.
Scaglione F, Cattaneo G, Alessandria M, Cogo R. Efficacy and safety of the standardized ginseng extract G115 for potentiating vaccination against the influenza syndrome and protection against the common cold [corrected]. Drugs Exp Clin Res. 1996;22(2):65-72. PMID 8879982 [published correction appears in Drugs Exp Clin Res. 1996;22:338].
Mitra SK, Chakraborti A, Bhattacharya SK. Neuropharmacological studies on panax ginseng. Indian J Exp Biol. 1996;34(1):41-7. PMID 8698406.
Tyler V. Herbs of choice: the therapeutic use of phytomedicinals. Binghamton, NY: pharmaceutical products press. Vol. 209; 1994.
De Smet PAGM, Keller K, Hansel R, Chandler R. Adverse effects of herbal drugs. Berlin, Germany: Springer Verlag; 1997. p. 250.
Lambert GA, Lang WJ, Friedman E, Meller E, Gershon S. Pharmacological and biochemical properties of isomeric yohimbine alkaloids. Eur J Pharmacol. 1978;49(1):39-48. doi: 10.1016/0014-2999(78)90220-0, PMID 658127.
Rasmusson AM, Southwick SM, Hauger RL, Charney DS. Plasma neuropeptide Y (N.P.Y.) increases in humans in response to the alpha 2 antagonist yohimbine. Neuropsychopharmacology. 1998;19(1):95-8. doi: 10.1016/S0893-133X(97)00199-1, PMID 9608581.
Published
How to Cite
Issue
Section
Copyright (c) 2022 Mohammad Rashid Iqbal, Gufran Ajmal, Manoj Kumar Sharma

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.